Dose groups 2 and 3 treated with the non selected clinical vehicles and variants are reported separately in Part B. COMPOUND_XXX was administered by dermal application every forty - seven hours ( 2 days ) to the left flank and every hundred - nineteen hours ( 5 days ) to the right flank .
Dose groups 2 and 3 treated with the non selected clinical vehicles and variants are reported separately in Part B. COMPOUND_XXX was administered by dermal application every forty - seven hours ( 2 days ) to the left flank and every hundred - nineteen hours ( 5 days ) to the right flank .
O B-GROUP I-GROUP I-GROUP I-GROUP O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O